Synthesis of 1,4-imino-L-lyxitols modified at C-5 and their evaluation as inhibitors of GH38 α-mannosidases

Scholarly Works

• Nemčovičová, I.; Kóňa, J.; Poláková, M.; Klunda, T.; Bitala, A.; Benko, M.; Lenhartová, S.; Nemčovič, M. Small glycomimetic antagonists of the cytomegalovirus glycoprotein UL141 prevent binding to TRAIL death receptor. The Journal of biological chemistry 2025, 301, 108490. doi:10.1016/j.jbc.2025.108490
• Kalník, M.; Šesták, S.; Kóňa, J.; Bella, M.; Poláková, M. Synthesis, α-mannosidase inhibition studies and molecular modeling of 1,4-imino-ᴅ-lyxitols and their C-5-altered N-arylalkyl derivatives. Beilstein journal of organic chemistry 2023, 19, 282–293. doi:10.3762/bjoc.19.24
• Kóňa, J.; Šesták, S.; Wilson, I. B. H.; Poláková, M. 1,4-Dideoxy-1,4-imino-D- and L-lyxitol-based inhibitors bind to Golgi α-mannosidase II in different protonation forms. Organic & biomolecular chemistry 2022, 20, 8932–8943. doi:10.1039/d2ob01545e
• Kalník, M.; Zajičková, M.; Kóňa, J.; Šesták, S.; Moncoľ, J.; Koóš, M.; Bella, M. Synthesis of hydroxymethyl analogues of mannostatin A and their evaluation as inhibitors of GH38 α-mannosidases. New Journal of Chemistry 2021, 45, 13539–13548. doi:10.1039/d1nj02351a
• Lee, Z. Y.; Loo, J. S. E.; Wibowo, A.; Mohammat, M. F.; Foo, J. B. Targeting cancer via Golgi α-mannosidase II inhibition: How far have we come in developing effective inhibitors?. Carbohydrate research 2021, 508, 108395. doi:10.1016/j.carres.2021.108395
• Klunda, T.; Hricovíni, M.; Šesták, S.; Kóňa, J.; Poláková, M. Selective Golgi α-mannosidase II inhibitors: N-alkyl substituted pyrrolidines with a basic functional group. New Journal of Chemistry 2021, 45, 10940–10951. doi:10.1039/d1nj01176f
• Rísquez-Cuadro, R.; Matsumoto, R.; Ortega-Caballero, F.; Nanba, E.; Higaki, K.; Fernández, J. M. G.; Mellet, C. O. Pharmacological Chaperones for the Treatment of α-Mannosidosis. Journal of medicinal chemistry 2019, 62, 5832–5843. doi:10.1021/acs.jmedchem.9b00153

Explore citations to this article at